SEPROGADIC – serum protein-based gastric cancer prediction model for prognosis and selection of proper adjuvant therapy

Gastric cancer (GC) patients usually receive surgical treatment. Postoperative therapeutic options such as anticancer adjuvant therapies (AT) based on prognostic prediction models would provide patient-specific treatment to decrease postsurgical morbidity and mortality rates. Relevant prognostic fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Hee-Sung, Sohn, Tae Sung, Kim, Mi Jeong, Cho, Byoung Kyu, Kim, Su Mi, Kim, Seung Tae, Yi, Eugene C., Lee, Cheolju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237900/
https://www.ncbi.nlm.nih.gov/pubmed/30442939
http://dx.doi.org/10.1038/s41598-018-34858-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237900/
https://www.ncbi.nlm.nih.gov/pubmed/30442939
http://dx.doi.org/10.1038/s41598-018-34858-x

Ejemplares similares